We have significantly increased production and have made steady progress on our commitment to restore Wegovy™ supply in the U.S. We are on track to stabilize supply in early 2022, if not sooner, depending on demand. You can call us at 1-833-4-WEGOVY (1-833-493-4689) from 9 AM to 6 PM Eastern Monday through Friday if you have questions or feedback – and select option 0 for more support. Read on for more details and please share any questions you may have. Thank you for your patience.

Since we made Wegovy™ available, there has been an unprecedented demand for this medicine, which has led to the current supply shortage. To everyone affected, we want to extend our sincere apologies. We want you to know we are doing all we can to make this right and that supporting you is our top priority. We understand this uncertainty is frustrating and we know you have questions. Our goal is to proactively communicate with those who have been impacted and provide up-to-date information on our progress toward restoring supply.

As we work to replenish supply, some people are experiencing an approximate one month or longer delay in filling prescriptions for Wegovy™.
  • This includes the four doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, for the first 16 weeks of treatment, as well as the 2.4 mg maintenance dose.
  • It is important that you, with the direction of your healthcare provider, follow this dose escalation schedule and are taking Wegovy™ as intended.

We expect delays to continue throughout 2021. However, we are making steady progress and are on track to stabilize supply in early 2022, if not sooner, depending on demand. Here are some of the recent steps we’ve taken to address the situation:

  • In the past month, we have increased production. Our production teams are working 24-hour shifts to restore supply.
  • Our field teams are working closely with healthcare providers to keep them up to date on the supply shortage so that they can be thoughtful in initiating or delaying treatment with Wegovy™.
  • To better answer your questions, we are increasing our proactive communications to share up-to-date information about our progress toward restoring supply.

We are here to help and ready to answer your questions at 1-833-4-WEGOVY (1 833-493-4689) from 9 AM to 6 PM Eastern Monday through Friday – and select option 0 for more support.

If you have already started Wegovy™ and are experiencing difficulties in finding certain doses, we encourage you to speak to your healthcare provider about the best course of action and the options available to you.

If you have already received a Wegovy™ prescription and have not been able to start your initial dose, we expect that you will likely be able to get your initial 0.25 mg starting dose prescription filled within the next several weeks. It is important to know and consider that you may experience disruptions in getting the other doses you will need to get to the 2.4 mg maintenance dose later this year. The staff at your local pharmacy are best suited to provide information about their availability of Wegovy™ – at the starting 0.25 mg dose, as well as the subsequent four doses. We recommend contacting them about your refills at least 1-2 weeks earlier than you normally would. In consideration of the supply constraints, it is important to discuss your treatment plan with your healthcare provider to determine when to start taking Wegovy™, or an alternative option that may make sense for you.

Wegovy™ is a prescription medicine indicated for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems to help them lose weight and keep it off used with a reduced-calorie meal plan and increased physical activity.

Please see below for important information, and don’t hesitate to call 1-833-4-WEGOVY (1-833-493-4689) and select option 0 for more support. You are our number one priority and we’re here to help.

Please click here for the Prescribing Information and Medication Guide.

Addressing these supply challenges and, in turn, supporting you is our top priority. We are on track to stabilize supply in early 2022, if not sooner, depending on demand. Thank you for your patience while we work to resolve this issue.

There are five different doses of Wegovy™: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg – and all doses have been impacted. Although we are making progress in the availability of the starting doses, if you have been prescribed Wegovy™ and initiate therapy now, you may experience delays with higher doses. We are working hard to restore supply by early 2022, if not sooner, depending on demand.

Please work with your healthcare provider to determine the best approach to your overall weight management plan. For more information about the Wegovy™ dosing schedule, please visit: www.wegovy.com/about-wegovy/dosing-schedule.html.

We recommend contacting your pharmacy about your refills at least 1-2 weeks earlier than you normally would, in consideration of the supply constraints.

If you are unable to find a dose, we encourage you to speak to your healthcare provider about your treatment plan to determine the best course of action and options available to you. Your healthcare provider knows your past and current medical history best and they are most equipped to make clinical recommendations.

There are five different doses of Wegovy™: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, and all dosages have been impacted. Although we are making progress in the availability of the starting doses, if you have been prescribed Wegovy™ and initiate therapy now, you may experience delays with higher dosages. We are working hard to restore supply by early 2022, if not sooner, depending on demand.

Know that there are other medicines FDA-approved for chronic weight management. Please work with your healthcare provider to determine the best approach to your overall weight management plan.

Thousands of pharmacies will carry Wegovy™ across the country as supply is replenished. Unfortunately, we don’t have access to which pharmacies will or won’t have Wegovy™ in stock, or where the best place to fill a Wegovy™ prescription would be nearest to you. Contact your local pharmacy for information about their ability to obtain Wegovy™ at the dose you need.

Please follow the dose escalation schedule in the Prescribing Information for Wegovy™. Importantly, the final decision as to whether and how you take this medication should be made together with your healthcare provider.

For more information about the Wegovy™ dosing schedule, click here for the Prescribing Information and Medication Guide.

Although Wegovy™ and Ozempic® both contain semaglutide, they are different products with different indications, dosages, titration schedules, etc. The products are not interchangeable. Please speak with your healthcare provider to discuss your treatment options.

The amount that you will pay for Wegovy once the Limited-Time Savings offer ends depends on your insurance coverage. We recommend that you immediately find out if you have prescription coverage for Wegovy™. The savings offer was intended for healthcare providers to extend to those patients with insurance coverage for anti-obesity medicines who were awaiting Wegovy™ to potentially be added to their prescription plan. So please check whether Wegovy™ is covered by your plan and if not, know there may be other ways to gain coverage. To learn more, visit: https://www.novocare.com/wegovy/cost-navigator.html

Obesity is recognized as a chronic disease and health issue by leading health organizations and the broader medical community. We know that this disease is influenced by many factors, including genetics, our biology and the environment – and that respect, support and care are so important. Novo Nordisk is partnering broadly to drive change and advocate for complete care when it comes to long-term weight management, including prescription medicines.

Was this helpful?

Was this helpful?

Let us know! Please rate your experience with this page. *

{{crossValidationError['Was this page helpful'].crossValidationErrorMessage}}

If you have additional comments or would like to provide feedback on what other information would be helpful to you, please contact our Customer Care Center at 1-800-727-6500 or submit online. We will be reviewing that information on an ongoing basis and making periodic updates to this page. Please know that we take our responsibility to support you in this journey very seriously and are addressing this issue as a top priority. Thank you for your patience as we work to resolve this issue – which we will.

Your Career Guide